Ireland
--:--IST
Recruiting Observational

Treatment of Hypertrichosis With Intense Pulsed Light

NCT05775328 · tracked via the Priya Life Science Sweden tracker
Sponsor
Alexander Shayesteh
Phase
Observational
Started
2023-12-01
Last updated
2025-04-08

Condition(s) studied

HypertrichosisHirsutism - Hypertrichosis

Investigational drug(s) / intervention(s)

Intense pulsed light

Intense pulsed light: Already described in the arm/group description

Study summary

The goal of this observational cohort study is to investigate the effect of intense pulsed light (IPL) for excessive hair in patients \>18 years of age and in need of gender affirmative treatment, refered to the department of dermatology and venereology, Umeå University Hospital, Sweden. The main questions this study aims to answer are:

* \[To evaluate the effect of consecutive IPL treatments in women with hirsutism due to polycystic ovarial syndrome (PCOS), with or without anti-androgen treatment\]
* \[To evaluate the effect of consecutive IPL treatments in individuals born as biologically men but in transition to become women, with or without hormonal treatment\].

Patients will use self-assessed questionnaires evaluating:

* Background characteristics and time spend on concealing, reducing and treating hypertrichosis at home.
* Ferriman-Gallwey scale, regarding the intensity of their hypertrichosis.
* Dermatology Life Quality Index (DLQI) for quality of life Patients will be recruited consecutively and assessed at each visit, at the clinic before the treatments, ranging from baseline to a minimum of 5 treatment sessions.Since this is an observational study, all patients are treated by others than the researchers according to the routines och the clonic and there will be no other groups to compare the patients with.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years of age and above * Diagnosis of PCOS obtained by a gynaecologist and hirsutism, * Diagnosis of gender dysphoria obtained after psychiatric evaluation, * ≥3 points in hair density according to Ferriman-Gallwey scale on a specific part of the body Exclusion Criteria: * Language barrier causing problem in understanding questionnaires or not being able to give consent * Hair colours of white, orange or grey hair * Skin type 5 and above according to Fitzpatrick * Hereditary hypertrichosis

Primary outcome measure(s)

  • DLQI — 2023-2025
    The scale of Dermatology Life Quality Index. Anticipated reduction by 3 mean points between basle-line and the last treatment session.

Trial sites (1)

FacilityCityRegionStatus
Norrlands University Hospital Umeå Västerbotten County Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05775328 on ClinicalTrials.gov ↗ ← All trials in Sweden